Article Details
Retrieved on: 2024-09-11 22:43:44
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Funds will be used to advance clinical trials for Incannex's lead product, IHL-42X, targeting OSA, and other drug candidates in the pipeline.
Article found on: sleepreviewmag.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here